TheranosticTrials.org

Clinical Trial · NCT00001160

Studies on Tumors of the Thyroid

Overview

Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Other tests are performed for research purposes. In addition, blood and tissue samples will be taken for research and genetic studies.

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases

Contacts

Padmasree Veeraraghavan, R.N. (CONTACT)

padmasree.veeraraghavan@nih.gov

(301) 451-7710

Joanna Klubo-Gwiezdzinska, M.D. (CONTACT)

joanna.klubo-gwiezdzinska@nih.gov

(301) 496-5052

Joanna Klubo-Gwiezdzinska, M.D. (PRINCIPAL_INVESTIGATOR)

ClinicalTrials.gov

NCT00001160

Drug / Compound

DOTATATE

Isotope(s):
Target(s):
  • SSTR2
Ligand Class: Peptides
Chelator: DOTA

Eligibility

Inclusion

  • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • At risk family members of patients who have a genetic susceptibility to developing thyroid cancer.
  • Patients with known or suspected thyroid nodules and/or thyroid cancer.

Exclusion

  • An individual who meets any of the following criteria will be excluded from participation in this study:1\. Serious underlying medical conditions that restrict diagnostic testing or therapy such as renal failure, congestive cardiac failure or active coexisting non-thyroid carcinoma requiring intervention before thyroid cancer is addressed.